Ortin Labs - Ortin Global Share Price

  • 11.63-0.09 (-0.77%)
  • Volume: 1,236
  • Live
  • Last Updated On: 03 Jul, 2025, 03:15 PM IST
Loading...
Ortin Labs - Ortin Global Share Price
  • 11.63-0.09 (-0.77%)
  • Volume: 1,236
Advertisment

Ortin Labs share price insights

View All
  • Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

  • Company has posted a loss of Rs 0.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)

  • Company has spent less than 1% of its operating revenues towards interest expenses and 40.0% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

  • Ortin Global Ltd. share price moved down by -0.77% from its previous close of Rs 11.72. Ortin Global Ltd. stock last traded price is 11.63

    Share PriceValue
    Today/Current/Last11.63
    Previous Day11.7211.97

InsightsOrtin Labs

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Key Metrics

    PE Ratio
    (x)
    -11.17
    EPS - TTM
    (₹)
    -1.04
    MCap
    (₹ Cr.)
    9.23
    Sectoral MCap Rank
    109
    PB Ratio
    (x)
    0.39
    Div Yield
    (%)
    0.00
    Face Value
    (₹)
    10.00
    Beta

    Beta

    1 Month-0.21
    3 Months1.51
    6 Months1.39
    1 Year1.24
    3 Years1.51

    -0.21
    VWAP
    (₹)
    11.49
    52W H/L
    (₹)
    24.82 / 9.64

    Ortin Labs Share Price Returns

    1 Day-0.77%
    1 Week-2.43%
    1 Month4.3%
    3 Months6.02%
    1 Year-42.14%
    3 Years-44.88%
    5 Years-22.47%

    ET Stock ScreenersTop Score Companies

    Check whether Ortin Labs belongs to analysts' top-rated companies list?

    View Stock Screeners

    Ortin Labs Share Analysis

    Unlock Stock Score, Analyst' Ratings & Recommendations

    Share Analysis Non Prime User
    • View Stock Score on a 10-point scale
    • See ratings on Earning, Fundamentals, Valuation, Risk & Price
    • Check stock performance
    JOIN ET PRIME

    Ortin Labs Share Recommendations

    No Recommendations details available for this stock.
    Check out other stock recos.

    Ortin Labs Financials

    • Insights

      • PAT: Troublesome Times

        Company has posted a loss of Rs 0.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)
      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 40.0% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)
      Quarterly | AnnualJun 2012Mar 2012
      Total Income15.9619.77
      Total Income Growth (%)-19.23-0.26
      Total Expenses14.1816.46
      Total Expenses Growth (%)-13.83-5.77
      EBIT1.783.31
      EBIT Growth (%)-46.1140.59
      Profit after Tax (PAT)0.441.43
      PAT Growth (%)-69.0918.57
      EBIT Margin (%)11.1716.74
      Net Profit Margin (%)2.767.21
      Basic EPS (₹)0.260.84
      Quarterly | AnnualMar 2025Dec 2024Sep 2024Jun 2024Mar 2024
      Total Income0.090.030.050.210.31
      Total Income Growth (%)157.61-36.19-75.14-31.65125.88
      Total Expenses0.250.150.510.313.41
      Total Expenses Growth (%)65.42-70.6362.96-90.8421.70
      EBIT-0.16-0.12-0.46-0.10-3.10
      EBIT Growth (%)-----
      Profit after Tax (PAT)-0.16-0.11-0.47-0.10-4.14
      PAT Growth (%)-----
      EBIT Margin (%)-186.56-346.27-869.71-47.92-1,003.88
      Net Profit Margin (%)-190.15-319.10-899.81-48.77-1,341.39
      Basic EPS (₹)-0.20-0.13-0.58-0.13-5.10
      Quarterly | Annual FY 2012
      Total Revenue85.86
      Total Revenue Growth (%)-
      Total Expenses78.74
      Total Expenses Growth (%)-
      Profit after Tax (PAT)4.62
      PAT Growth (%)-
      Operating Profit Margin (%)12.10
      Net Profit Margin (%)5.38
      Basic EPS (₹)2.73
      Quarterly | Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Revenue0.382.286.068.438.22
      Total Revenue Growth (%)-83.22-62.31-28.052.53-95.84
      Total Expenses1.249.366.158.968.08
      Total Expenses Growth (%)-86.7552.28-31.3710.82-95.89
      Profit after Tax (PAT)-0.85-8.04-0.09-0.400.95
      PAT Growth (%)----142.17-
      Operating Profit Margin (%)-222.68-312.195.193.4012.36
      Net Profit Margin (%)-220.70-380.81-1.55-4.8411.57
      Basic EPS (₹)-1.04-9.89-0.12-0.491.16

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2012
      Total Assets81.52
      Total Assets Growth (%)-
      Total Liabilities57.01
      Total Liabilities Growth (%)-
      Total Equity24.51
      Total Equity Growth (%)-
      Current Ratio (x)1.11
      Total Debt to Equity (x)0.58
      Contingent Liabilities0.00
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Total Assets3.786.6621.2020.7021.27
      Total Assets Growth (%)-43.24-68.582.42-2.68-81.75
      Total Liabilities1.803.8410.339.759.91
      Total Liabilities Growth (%)-53.13-62.835.95-1.61-89.31
      Total Equity1.982.8210.8610.9611.36
      Total Equity Growth (%)-29.79-74.03-0.91-3.52-52.31
      Current Ratio (x)2.393.110.940.760.78
      Total Debt to Equity (x)0.130.640.590.560.61
      Contingent Liabilities0.00----

      All figures in Rs Cr, unless mentioned otherwise

    • Annual FY 2012
      Net Cash flow from Operating Activities0.00
      Net Cash used in Investing Activities0.00
      Net Cash flow from Financing Activities0.00
      Net Cash Flow0.00
      Closing Cash & Cash Equivalent0.00
      Closing Cash & Cash Equivalent Growth (%)-
      Total Debt/ CFO (x)-
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Net Cash flow from Operating Activities-0.41-4.79-0.252.1518.03
      Net Cash used in Investing Activities0.0012.000.01-0.130.07
      Net Cash flow from Financing Activities0.33-3.490.90-0.48-9.86
      Net Cash Flow-0.093.720.661.558.25
      Closing Cash & Cash Equivalent0.370.46-3.26-3.92-5.47
      Closing Cash & Cash Equivalent Growth (%)-18.64-114.07-16.79-28.34-60.10
      Total Debt/ CFO (x)-0.61-0.38-25.452.850.38

      All figures in Rs Cr, unless mentioned otherwise

    • Insights

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)
      Annual FY 2012
      Return on Equity (%)18.85
      Return on Capital Employed (%)34.77
      Return on Assets (%)5.67
      Interest Coverage Ratio (x)3.63
      Asset Turnover Ratio (x)-
      Price to Earnings (x)10.44
      Price to Book (x)1.97
      EV/EBITDA (x)5.27
      EBITDA Margin (%)13.81
      Annual FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
      Return on Equity (%)-42.80-284.74-0.86-3.638.32
      Return on Capital Employed (%)-38.33-142.492.192.147.54
      Return on Assets (%)-22.38-120.65-0.44-1.924.44
      Interest Coverage Ratio (x)-311.96-13.201.420.711.48
      Asset Turnover Ratio (x)0.070.150.290.390.12
      Price to Earnings (x)-9.60-1.80-151.52-46.3027.78
      Price to Book (x)4.115.131.301.682.31
      EV/EBITDA (x)-9.49-2.1936.1341.6625.47
      EBITDA Margin (%)-219.63-301.389.346.9715.85

    Financial InsightsOrtin Labs

    • Income (P&L)
    • Ratios
      • PAT: Troublesome Times

        Company has posted a loss of Rs 0.16 cr for the 4th consecutive quarter. (Source: Standalone Financials)

      • Employee & Interest Expense

        Company has spent less than 1% of its operating revenues towards interest expenses and 40.0% towards employee cost in the year ending Mar 31, 2025. (Source: Standalone Financials)

      • Losing Shareholder's Money

        Company has reported a negative ROE for 3 consecutive years. (Source: Standalone Financials)

    Do you find these insights useful?

    • hate it

    • meh

    • love it

    Ortin Labs Technicals

    • Stock doesn't have any Buy/Sell Signals.

    • Price Analysis Data details are not available.

    • Pivot Levels

      R1R2R3PIVOTS1S2S3
      Classic-------

      Average True Range

      5 DAYS14 DAYS28 DAYS
      ATR---

    Ortin Labs Peer Comparison

      • 1D
      • 1W
      • 1M
      • 3M
      • 6M
      • 1Y
      • 5Y
      Loading...
    • Ratio Performance

      NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
      Ortin Labs-11.170.3918.8534.775.67-63.9312.105.382.731.110.580.00
      Alpa Labs11.181.2811.3714.728.763.3123.0317.349.344.100.000.00
      Bafna Pharma50.874.130.00-3.29-34.6719.21-4.20-57.54-15.522.11-0.71-0.09
      Aarey Drugs50.011.452.907.151.68-0.782.130.841.842.200.253.61
      Krebs Biochem-6.87-1.270.00-32.07-15.93-10.14-48.50-62.19-12.490.10-1.45-26.89
      Add More
      Annual Ratios (%)

      Choose from Peers

      • Bal Pharma
      • Mangalam Drugs
      • Vaishali Pharma
      • Par Drugs & Chemical
      • Ind Swift Ltd

      Choose from Stocks

      Peers InsightsOrtin Labs

        Do you find these insights useful?

        • hate it

        • meh

        • love it

        Ortin Labs Shareholding Pattern

        • Loading...
          Showing Ortin Labs Shareholding as on Mar 2025
          CategoryMar 2025Dec 2024Sep 2024Jun 2024
          Promoters1.231.231.231.23
          Pledge0.000.000.000.00
          FII6.536.256.256.25
          DII0.000.000.000.00
          Mutual Funds0.000.000.000.00
          Others92.2492.5292.5292.52
        • Showing Shareholding as on Mar 2025
          CategoryNo. of SharesPercentage% Change QoQ
          Promoters1,00,3001.23 %0.00
          Pledge00.00 %0.00
          FII5,30,7286.53 %0.28
          Others75,00,36492.24 %-0.28

        Ortin Labs MF Ownership

        MF Ownership details are not available.

        Ortin Labs Corporate Actions

        • Meeting DateAnnounced onPurposeDetails
          May 26, 2025May 19, 2025Board MeetingAudited Results
          Feb 12, 2025Feb 07, 2025Board MeetingQuarterly Results
          Nov 13, 2024Nov 04, 2024Board MeetingQuarterly Results
          Sep 30, 2024Aug 13, 2024AGM-
          Aug 13, 2024Aug 06, 2024Board MeetingQuarterly Results
        • TypeDividendDividend per ShareEx-Dividend DateAnnounced on
          Final2%0.25Sep 24, 2013Jun 05, 2013
          Final5%0.5Sep 24, 2012Aug 31, 2012
          Final 5%0.5Oct 13, 2011Sep 29, 2011
          Final 8%0.8Sep 23, 2010Aug 26, 2010
          Final 8%0.8Sep 23, 2009Sep 02, 2009
        • No other corporate actions details are available.

        About Ortin Labs

        Ortin Global Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 9.53 Crore) operating in Pharmaceuticals sector. Ortin Global Ltd. key Products/Revenue Segments include Drugs & Pharmaceuticals for the year ending 31-Mar-2024. Show More

        • Executives

        • Auditors

        • SM

          S Murali Krishna Murthy

          Managing Director
          SS

          S Srinivas Kumar

          Whole Time Director
          PD

          Pramod Dnyandeo Waghe

          Non Executive Director
          SB

          S Balaji Venkateswarlu

          Non Executive Director
          Show More
        • Mathesh & Ramana
          Sathuluri & Co.

        FAQs about Ortin Labs share

        • 1. What's the Ortin Labs share price today?
          Ortin Labs share price is Rs 11.63 as on 04 Jul, 2025, 01:03 PM IST. Ortin Labs share price is down by 0.77% based on previous share price of Rs. 11.87. In last 1 Month, Ortin Labs share price moved up by 4.30%.
        • 2. What are the returns for Ortin Labs share?
          Return Performance of Ortin Labs Shares:
          • 1 Week: Ortin Labs share price moved down by 2.43%
          • 1 Month: Ortin Labs share price moved up by 4.30%
          • 3 Month: Ortin Labs share price moved up by 6.02%
          • 6 Month: Ortin Labs share price moved down by 34.88%
        • 3. What is the PE & PB ratio of Ortin Labs?
          The PE ratio of Ortin Labs stands at -11.26, while the PB ratio is 4.82.
        • 4. What has been highest price of Ortin Labs share in last 52 weeks?
          52 Week high of Ortin Labs share is Rs 24.82 while 52 week low is Rs 9.64
        • 5. What is the market cap of Ortin Labs?
          Market Capitalization of Ortin Labs stock is Rs 9.23 Cr.

        Trending in Markets

        Top Gainers As on 01:20 PM | 04 Jul 2025

        Chennai Petro771.70
        59.31 (8.33%)
        Sapphire Foods344.70
        24.15 (7.54%)
        CreditAccess Grameen1,319.80
        78.80 (6.35%)
        Kirloskar Bros.2,368.60
        126.00 (5.62%)
        Niva Bupa Health Ins85.40
        3.44 (4.19%)

        Top Losers As on 01:20 PM | 04 Jul 2025

        Trent5,499.50
        -691.50 (-11.17%)
        Nuvama Wealth Mgmt7,344.00
        -831.50 (-10.18%)
        Ibull Housing Fin123.95
        -11.78 (-8.68%)
        BSE2,645.80
        -174.30 (-6.19%)
        Angel One2,773.70
        -176.91 (-6.00%)

        DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

        DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

        By using this site, you agree to the Terms of Service and Privacy Policy.

        The Economic Times
        OSZAR »